Kimberley Kallsen is a cell biologist by training and holds a PhD and a master in public health. She joined Boehringer Ingelheim in 2013, worked in different global strategic and operational roles including medical writing, scientific publications, patient engagement, and is currently Head of Global Clinical Development & Operations Patient & Site Engagement. She is passionate about early partnerships with patient representatives and healthcare professionals to ensure patient- and site-centric clinical trials.